Guardant Health, Inc.Guardant Health, Inc.Guardant Health, Inc.

Guardant Health, Inc.

No trades
See on Supercharts
Market capitalization
‪1.97 B‬USD
−4.28USD
‪−479.45 M‬USD
‪563.95 M‬USD
‪115.88 M‬
Beta (1Y)
1.42

About Guardant Health, Inc.

Headquarters
Palo Alto
Employees (FY)
‪1.78 K‬
Founded
2011
ISIN
US40131M1099
FIGI
BBG006D97VY9
Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2011 and is headquartered in Palo Alto, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GH is 16.39 USD — it has increased by 1.42% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Guardant Health, Inc. stocks are traded under the ticker GH.
Guardant Health, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Guardant Health, Inc. has a max estimate of 54.00 USD and a min estimate of 27.00 USD.
GH earnings for the last quarter are −0.73 USD whereas the estimation was −0.97 USD which accounts for 24.55% surprise. Estimated earnings for the next quarter are −0.86 USD. See more details about Guardant Health, Inc. earnings.
Guardant Health, Inc. revenue for the last quarter amounts to ‪143.03 M‬ USD despite the estimated figure of ‪137.35 M‬ USD. In the next quarter revenue is expected to reach ‪149.60 M‬ USD.
Yes, you can track Guardant Health, Inc. financials in yearly and quarterly reports right on TradingView.
GH stock has fallen by 10.39% compared to the previous week, the month change is a 7.92% fall, over the last year Guardant Health, Inc. has showed a 35.68% decrease.
Like other stocks, GH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Guardant Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
GH reached its all-time high on Feb 12, 2021 with the price of 181.07 USD, and its all-time low was 16.92 USD and was reached on Mar 26, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪1.78 K‬ employees. See our rating of the largest employees — is Guardant Health, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Guardant Health, Inc. EBITDA is ‪−519.91 M‬ USD, and current EBITDA margin is −92.14%. See more stats in Guardant Health, Inc. financial statements.